Comparison of screened and nonscreened breast cancer patients in relation to age: A 2-institution study

Clinical Breast Cancer

Volumn 15, Issue 6, 2015, Pages 482-489

  Barco, Israel ^a   Chabrera, Carol ^b   García Font, Marc ^c   Gimenez, Nuria ^d,e   Fraile, Manel ^a   Lain, Josep María ^f   Piqueras, Merce ^a   Vidal, M Carmen ^g   Torras, Merce ^a   González, Sonia ^a   Pessarrodona, Antoni ^a   Barco, Josep ^h   Cassadó, Jordi ^a   García Fernández, Antonio ^a,g  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b Edifici TecnoCampus v 10   (Spain)

^c UNIVERSITAT INTERNACIONAL DE CATALUNYA   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

^e UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^f HOSPITAL DE TERRASSA   (Spain)

^g INSTITUT CATALÀ DE LA SALUT   (Spain)

^h Clínica Sant Josep   (Spain)

Author keywords

Breast neoplasm; Mortality; Recurrence; Screening; Survival

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SCREENING; CANCER SURVIVAL; DISEASE FREE INTERVAL; DISTANT METASTASIS; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MASS SCREENING; MULTICENTER STUDY; PROSPECTIVE STUDY; TUMOR VOLUME; AGE; BREAST NEOPLASMS; CLINICAL TRIAL; COMPARATIVE STUDY; EARLY CANCER DIAGNOSIS; MAMMOGRAPHY; MIDDLE AGED; MORTALITY;

AGE FACTORS; AGED; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED;

EID: 84947022889     PISSN: 15268209     EISSN: 19380666     Source Type: Journal    
DOI: 10.1016/j.clbc.2015.04.007     Document Type: Article

References (39)

1. M. Baum, and P.M. Ravdin Decision-making in early breast cancer: guidelines and decision tools Eur J Cancer 38 2002 745 749
2. M.J. Silverstein, K.A. Skinner, and T.J. Lomis Predicting axillary nodal positivity in 2282 patients with breast carcinoma World J Surg 25 2001 767 772
3. M. Kalager, M. Zelen, F. Langmark, and H.O. Adami Effect of screening mammography on breast-cancer mortality in Norway N Engl J Med 363 2010 1203 1210
4. D.A. Berry, K.A. Cronin, S.K. Plevritis, and et al. Effect of screening and adjuvant therapy on mortality from breast cancer N Engl J Med 353 2005 1784 1792
5. M.M. Vervoort, G. Draisma, J. Fracheboud, L.V. van de Poll-Franse, and H.J. de Koning Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality Br J Cancer 91 2004 242 247
6. A. García, C. Chabrera, M. García, and et al. Mortality and recurrence patterns of breast cancer patients diagnosed under a screening programme versus comparable non-screened breast cancer patients from the same population: analytical survey from 2002 to 2012 Tumour Biol 35 2014 1945 1953
7. D.B. Spencer, J.E. Potter, M.A. Chung, J. Fulton, W. Hebert, and B. Cady Mammographic screening and disease presentation of breast cancer patients who die of disease Breast J 10 2004 298 303
8. K.M. Joyce, N.M. McInerney, P.S. Waters, K.J. Sweeney, K. Barry, and M.J. Kerin Symptomatic breast cancer diagnosis and multimodal management in women aged 40 to 50 years; consequences of current mammographic screening programs Clin Breast Cancer 15 2015 e125 e130
9. M.L. Webb, B. Cady, J.S. Michaelson, and et al. A failure analysis of invasive breast cancer: most deaths from disease occur in women not regularly screened Cancer 120 2014 2839 2846
10. S. Hofvind, A. Ponti, J. Patnick, and et al. False-positive results in mammographic screening for breast cancer in Europe: a literature review and survey of service screening programmes J Med Screen 19 suppl 1 2012 57 66
11. N. Perry, M. Broeders, C. de Wolf, S. Törnberg, R. Holland, and L. von Karsa European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition Ann Oncol 19 2008 614 622
12. P. Autier, M. Boniol, A. Gavin, and L.J. Vatten Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database BMJ 343 2011 d4411
13. K.R. Beckmann, D.M. Roder, J.E. Hiller, G. Farshid, and J.W. Lynch Do breast cancer risk factors differ among those who do and do not undertake mammography screening? J Med Screen 20 2013 208 219
14. R. Tresserras, E. Séculi, C. Masuet, and P. Brugulat The practice of preventive mammography in Catalonia [Spain]: a step forward Gac Sanit 18 2004 321 325
15. D. Salas, J. Ibáñez, R. Román, and et al. Effect of start age of breast cancer screening mammography on the risk of false-positive results Prev Med 53 2011 76 81
16. L.M. Schwartz, S. Woloshin, H.C. Sox, and H. Welch US women's attitudes to false positive mammography results and detection of ductal carcinoma in situ: cross sectional survey BMJ 320 2000 1635 1640
17. L. Ndkhlyudov, D. Ross-Degnan, and S.W. Fletcher Beliefs and expectations of women under 50 years old regarding screening mammography: a qualitative study J Gen Intern Med 18 2003 182 189
18. E. Silverman, S. Woloshin, L.M. Schwartz, S.J. Byram, H.G. Welch, and B. Fischhoff Women's views on breast cancer risk and screening mammography: a qualitative interview study Med Decis Making 21 2001 231 240
19. I. Andersson, and L. Janzon Reduced breast cancer mortality in women under age 50: updated results from the Malmo Mammographic Screening Programme J Natl Cancer Inst Monogr 22 1997 63 67
20. N. Bjurstam, L. Björneld, S.W. Duffy, and et al. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization Cancer 80 1997 2091 2099
21. H. Jonsson, S. Törnberg, L. Nyström, and P. Lenner Service screening with mammography in Sweden- evaluation of effects of screening on breast cancer mortality in age group 40-49 years Acta Oncol 39 2000 617 623
22. S. Buseman, J. Mouchawar, N. Calonge, and T. Byers Mammography screening matters for young women with breast carcinoma: evidence of downstaging among 42-49-year-old women with a history of previous mammography screening Cancer 97 2003 352 358
23. B.N. Hellquist, S.W. Duffy, S. Abdsaleh, and et al. Effectiveness of population-based service screening with mammography for women ages 40 to 49 years: evaluation of the Swedish Mammography Screening in Young Women (SCRY) cohort Cancer 117 2011 714 722
24. K. Kerlikowske, D. Grady, S.M. Rubin, C. Sandrock, and V.L. Ernster Efficacy of screening mammography. A meta-analysis JAMA 273 1995 149 154
25. R.E. Hendrick, R.A. Smith, J.H. Rutledge 3rd, and C.R. Smart Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials J Natl Cancer Inst Monogr 22 1997 87 92
26. P.P. Glasziou, A.J. Woodward, and C.M. Mahon Mammographic screening trials for women aged under 50. A quality assessment and meta-analysis Med J Aust 162 1995 625 629
27. J.M. Elwood, B. Cox, and A.K. Richardson The effectiveness of breast cancer screening by mammography in younger women Online J Curr Clin Trials 1993 Doc No 32
28. L. Nystrom, I. Andersson, N. Bjurstam, J. Frisell, B. Nordenskjöld, and L.E. Rutqvist Long-term effects of mammography screening: updated overview of the Swedish randomized trials Lancet 359 2002 909 919
29. A. Jemal, A. Thomas, T. Murray, and M. Thun Cancer statistics, 2002 [published errata appear in 2002; 52:119, and 2002; 52:181-182] CA Cancer J Clin 52 2002 23 45
30. S.A. Feig Mammographic screening of women aged 40-49 years: is it justified? Obstet Gynecol Clin North Am 21 1994 587 606
31. B.N. Curpen, E.A. Sickles, R.A. Sollitto, S.H. Ominsky, H.B. Galvin, and S.D. Frankel The comparative value of mammographic screening for women 40-49 years old versus women 50-64 years old AJR Am J Roentgenol 164 1995 1099 1103
32. D.E. Wazer, I. Gage, M.J. Homer, S.H. Krosnick, and C. Schmid Age related differences in patients with nonpalpable breast carcinomas Cancer 78 1996 1432 1437
33. E.L. Thurfjell, and J.A. Lindgren Breast cancer survival rates with mammographic screening: similar favourable survival rates for women younger and those older than 50 years Radiology 201 1996 421 426
34. C.R. Smart Highlights of the evidence of benefit for women aged 40-49 years from the 14-year follow-up of the Breast Cancer Detection Demonstration Project Cancer 74 1994 296 300
35. Chu Ck, C.R. Smart, and R.E. Tarone Analysis of breast cancer mortality and stage distribution by age for the Health Insurance Plan clinical trial J Natl Cancer Inst 80 1998 1125 1132
36. E.P. McCarthy, R.B. Burns, K.M. Freund, and et al. Mammography use, breast cancer stage at diagnosis, and survival among older women J Am Geriatr Soc 48 2000 1226 1233
37. J.L. Patnaik, T. Byers, C. Diguiseppi, T.D. Denberg, and D. Dabelea The influence of comorbidities on overall survival among older women diagnosed with breast cancer J Natl Cancer Inst 103 2011 1101 1111
38. R.M. Faulk, E.A. Sickles, R.A. Sollitto, S.H. Ominsky, H.B. Galvin, and S.D. Frankel Clinical efficacy of mammographic screening in the elderly Radiology 194 1995 193 197
39. C. Bouchardy, E. Rapiti, G. Fioretta, and et al. Undertreatment strongly decreases prognosis of breast cancer in elderly women J Clin Oncol 21 2003 3580 3587